Literature DB >> 2844691

Immunohistochemical analysis of breast cancer oestrogen receptor status and its correlation with oestrogen receptor biochemical assay.

P Johnston, P Dervan, M McAllister, M J Duffy, D N Carney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2844691     DOI： 10.1007/bf02949306

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  10 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.

Authors:  R A McClelland; U Berger; L S Miller; T J Powles; R C Coombes
Journal:  J Clin Oncol       Date:  1986-08       Impact factor: 44.544

3.  Improved sensitivity in the measurement of estrogen receptor in human breast cancer.

Authors:  W L McGuire; M DeLaGarza
Journal:  J Clin Endocrinol Metab       Date:  1973-12       Impact factor: 5.958

4.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

5.  Estrogen-binding substances of target tissues.

Authors:  E V Jensen; T Suzuki; M Numata; S Smith; E R DeSombre
Journal:  Steroids       Date:  1969-04       Impact factor: 2.668

6.  Comparison of histochemical and biochemical assays for estrogen receptor in human breast cancer cell lines.

Authors:  F F Parl; N T Wetherall; S Halter; S Schuffman; W M Mitchell
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

7.  Hormone dependency of breast cancer.

Authors:  E V Jensen
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

8.  Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.

Authors:  A Shimada; S Kimura; K Abe; K Nagasaki; I Adachi; K Yamaguchi; M Suzuki; T Nakajima; L S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

9.  Monoclonal antibodies to human estrogen receptor.

Authors:  G L Greene; C Nolan; J P Engler; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.

Authors:  W J King; E R DeSombre; E V Jensen; G L Greene
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701
  10 in total
  1 in total

1.  The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy?

Authors:  Tatiana A Bogush; Anna A Basharina; Elena A Bogush; Alexander M Scherbakov; Mikhail M Davydov; Vyacheslav S Kosorukov
Journal:  Ir J Med Sci       Date:  2021-11-06       Impact factor: 2.089
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.